Boston Scientific's Chronic Total Occlusion (CTO) System is designed to address the challenges of recanalizing coronary arteries that are completely blocked. Explore advancements in the future of cardiac care in this technology overview.
Safety info: bit.ly/3EouLvn
©2025 Boston Scientific Corporation or its affiliates. All rights reserved. All trademarks are the property of their respective owners.
Prior to use, please see the complete “Directions for Use” for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator’s Instructions at www.IFU-BSCI.com. Rx only. IC-434111-AA | CRM-2110407-AA
コメント